Методологические аспекты и этические проблемы исследований COVID-19
- Авторы: Романов Р.В.1
-
Учреждения:
- ФГБОУ ВО «Курский государственный медицинский университет» Минздрава России
- Выпуск: Том 22, № 1 (2022)
- Страницы: 9-12
- Раздел: ИНФЕКЦИОННЫЕ БОЛЕЗНИ
- URL: https://bakhtiniada.ru/2410-3764/article/view/90368
- DOI: https://doi.org/10.55531/2072-2354.2022.22.1.9-12
- ID: 90368
Цитировать
Полный текст
Аннотация
В статье представлен краткий анализ методологических проблем и этических нарушений, связанных с эпохой COVID-19 и трансформацией науки. Внимание акцентируется на принципе open science, который, будучи локальным явлением, приобрел массовый характер. Открытость исследований для общественности позволила выявить методологические проблемы, которые обусловливают неблагоприятные последствия для системы здравоохранения. Обсуждаются этические проблемы, разграничение макро- и микроэтики, следование общечеловеческим ценностям и личным интересам.
Ключевые слова
Полный текст
Открыть статью на сайте журналаОб авторах
Роман Витальевич Романов
ФГБОУ ВО «Курский государственный медицинский университет» Минздрава России
Автор, ответственный за переписку.
Email: rrv2019@yandex.ru
ORCID iD: 0000-0002-1469-4053
SPIN-код: 7956-7508
студент 3 курса
Россия, КурскСписок литературы
- Hu B, Guo H, Zhou P, Shi ZL. Characteristics of SARS-CoV-2 and COVID-19. Nature reviews. Microbiology. 2021;19(3):141-154. doi: 10.1038/s41579-020-00459-7
- Ipekci AM, Buitrago-Garcia D, Meili KW, et al. Outbreaks of publications about emerging infectious diseases: the case of SARS-CoV-2 and Zika virus. BMC Medical Research Methodo-logy. 2021;21(1):50. doi: 10.1186/s12874-021-01244-7
- Jones CW, Adams AC, Murphy E, et al. Delays in reporting and publishing trial results during pandemics: cross sectional analysis of 2009 H1N1, 2014 Ebola, and 2016 Zika clinical trials. BMC Medical Research Methodology. 2021;21(1):120. doi: 10.1186/s12874-021-01324-8
- Valmorri L, Vertogen B, Zingaretti C, et al. Clinical research activities during COVID-19: the point of view of a promoter of academic clinical. BMC Medical Research Methodology. 2021;21(1):91. doi: 10.1186/s12874-021-01291-0
- Mainoli B, Machado T, Duarte GS, et al. Analysis of clinical and methodological characteristics of early COVID-19 treatment clinical trials: so much work, so many lost opportunities. BMC Medical Research Methodology. 2021;21(1):42. doi: 10.1186/s12874-021-01233-w
- Mejia CR, Valladares-Garrido MJ, Miñan-Tapia A, et al. Use, knowledge, and perception of the scientific contribution of Sci-Hub in medical students: Study in six countries in Latin America. PLoS One. 2017;12(10):e0185673. doi: 10.1371/journal.pone.0185673
- Advancing discovery: How we are helping the research community to advance discovery: Spinger Nature. Available at: https://www.springernature.com/gp/advancing-discovery . Acessed: 2019 December 12.
- Sailer M, Stadler M, Botes E, et al. Science knowledge and trust in medicine affect individuals’ behavior in pandemic crises. European Journal of Psychology of Education. 2021;37(1):279-292.
- Homolak J, Kodvanj I, Virag D. Preliminary analysis of COVID-19 academic information patterns: a call for open science in the times of closed borders. Scientometrics. 2020;124:2687-2701. doi: 10.1007/s11192-020-03587-2
- El-Menyar A, Mekkodathil A, Asim M, et al. Publications and retracted articles of COVID-19 pharmacotherapy-related research: A systematic review. Science Progress. 2021;104(2). doi: 10.1177/00368504211016936
- Alexander PE, Debono VB, Mammen MJ, et al. COVID-19 coronavirus research has overall low methodological quality thus far: case in point for chloroquine/hydroxychloroquine. Journal of Clinical Epidemiology. 2020;123:120-126. doi: 10.1016/j.jclinepi.2020.04.016
- Wong JC. Hydroxychloroquine and coronavirus: a guide to the scientific studies so far. The Guardian. 2020 Apr 24.
- Yongshen F, Ting Zh, Yaxue H, et al. A data-mining based analysis of traditional Chinese medicine in diagnosing and treating COVID-19. The Anatomical Record: Advances in Integrative Anatomy and Evolutionary Biology. 2021;10:1002. doi: 10.1002/ar.24677
- Taherian Z, Rezaei M, Haddadpour A, Amini Z. RETRACTED ARTICLE: The Effect of COVID-19 Vaccination on Reducing the Risk of Infection, Hospitalization, and Death in Isfahan Pro-vince, Iran. Iran Journal of Public Health. 2022;51(1):188-195. doi: 10.18502/ijph.v51i2.8707
- Rupasinghe CD, Kantas T, Sani R, et al. RETRACTION: Comparison of High-Statin Therapy vs Moderate-Statin Therapy in Achieving Positive Low-Density Lipoprotein Change in Patients After Acute Coronary Syndrome: A Randomized-Control Trial. Cureus. 2022,14(3):r51. doi: 10.7759/cureus.r51
- Hays P. Clinical sequelae of the novel coronavirus: does COVID-19 infection predispose patients to cancer? RETRACTION NOTICE. Future Oncology. 2020;16(20):1463-1474 doi: 10.2217/fon-2020-0300r1
- RETRACTION: Coronavirus disease-2019: A brief compilation of facts. Journal of Oral and Maxillofacial Pathology. 2020;24(2):407. doi: 10.4103/0973-029X.294654
- Funck-Brentano C, Nguyen LS, Salem JE. RETRACTION AND REPUBLICATION: Cardiac toxicity of hydroxychloroquine in COVID-19. The Lancet. 2020;396(10245):e2-e3. doi: 10.1016/s0140-6736(20)31528-2
- Hui EC. Doctors as fiduciaries: do medical professionals have the right not to treat? Poiesis & Praxis. 2005;3:256-276. doi: 10.1007/s10202-005-0009-9
- Salam Z, Nouvet E, Schwartz L. Reflections of methodo-logical and ethical challenges in conducting research during COVID-19 involving resettled refugee youth in Canada. Journal of Medical Ethics. 2021. doi: 10.1136/medethics-2021-107291
Дополнительные файлы
